Secondary imaging analysis of a placebo-controlled RCT in 29 participants with alcohol use disorder: high-dose baclofen (75 mg/day), but not low dose (30 mg/day), was associated with altered resting brain connectivity vs placebo; links to drinking outcomes were non-significant.
RCTn = 29
Logge et al. Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment-Seeking Individuals With Alcohol Use Disorder